Precision Medicine Market Players:
- Novartis
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Tepnel Pharma Services
- Qiagen
- Menarini Silicon Biosystems
- Eagle Genomics
- Quest Diagnostics
- Pfizer
- Roche
- Biocrates Life Sciences
- Teva Pharmaceutical
- NanoString Technologies
Major players in the precision medicine market are strategically advancing the field through recent approvals in RNA treatments, cell and gene therapies, and other areas. These firms are leading the way in developing specific and effective treatments, which is driving the growth of the market.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of precision medicine is assessed at USD 123.86 billion.
The global precision medicine market size surpassed USD 108.87 billion in 2025 and is projected to grow at a CAGR of more than 15.3%, reaching USD 452.07 billion revenue by 2035.
The North America precision medicine market is anticipated to capture 45% share by 2035, driven by well-defined regulatory processes and increasing adoption of personalized medicine.
Key players in the market include Tepnel Pharma Services, Qiagen, Menarini Silicon Biosystems, Eagle Genomics, Quest Diagnostics, Pfizer, Roche, Biocrates Life Sciences, Teva Pharmaceutical, NanoString Technologies.
